Daily Brief India: KPIT Technologies, Samvardhana Motherson International, JSW One, Advanta Enterprises Limited, RPSG Ventures, Manipal Health Enterprises and more

• Despite a tough macro environment, KPIT posted decent earnings in Q1FY27. As opposed to expectation of -1% YoY de-growth, KPIT posted 0.1% growth in constant currency (CC) terms.
• QoQ, de-growth in revenue was -3.6% vs -5.0% guided. EBITDA margin compressed from earlier 20%+ levels to 17.2% due to operating de-leverage. Deals wins however were strong at $257mm.
• Macroenvironment has been tough for OEMs mainly due to competition from Chinese OEMs both in China and in Europe. Furthermore, tariffs and war led inflation have worsened the situation.

• Motherson has agreed to acquire 50.1% of Rotary Connectors. This transaction adds a critical interconnect component to the group’s aerospace and defence Electrical Wiring Interconnect System capability.
• Aerospace revenue has grown from INR 245 crore in FY23 to INR 2,447 crore in FY26, while the order book reached USD 1.6 billion at FY26-end. 
• FY26 aerospace EBITDA margin was only about 8.3%, well below the smaller pre-acquisition FY24-base. The next leg depends on mix, utilisation, integration and return on capital, not revenue growth alone.

• JSW One Platforms (JSWONE IN) is looking to raise about US$400m in its upcoming India IPO. The deal will be run by JM Fin, Kotak, ICICI, SBI Caps, PL Cap.
• JSW One Platforms (JSOPL) is a technology-enabled B2B commerce platform focused on manufacturing-construction materials, which combines marketplace commerce-distribution- fulfilment, processing/customisation, private brands, logistics, embedded financing and direct lending to MSMEs.
• According to the 1Lattice report, JSOPL was one of the fastest-growing business-to-business (B2B) commerce players in India, as of June 2026.

• Advanta Enterprises Limited (2085631D IN) (AEL) is looking to raise about US$500m in its upcoming India IPO. It is a 100% secondary offering. 
• AEL is a global agriculture solutions company offering hybrid seeds and post harvest solutions, with over 900 seed varieties across multiple crops, sold in 74 countries.
• In this note, we talk about the company’s historical performance.

• FMCG revenues jumped to INR 170cr in Q1FY27 vs typical run-rate of INR 130-140cr earlier, while the EBIT loss also narrowed to around INR -45cr vs INR -60cr+ YoY. 
• The Property business saw -10% YoY decline in revenue to INR 30cr+ due to impact on footfalls from ongoing renovation in the Quest Mall in Kolkata.
• The BPO Business (Firstsource Solutions) continues to see strong growth and margin expansion. QoQ revenue grew by 2.2% in constant currency (CC) terms while EBIT margin expanded 20bp QoQ.

• The IPO is a Deleveraging Tool for Parent UPL, Not a Growth Engine for Advanta: The planned USD 500 million listing is structured as a 100% Offer for Sale (OFS) of 36,105,578 shares. Advanta will receive zero fresh proceeds; the capital flows entirely up to parent company UPL Limited and KKR’s Melwood vehicle. This is a strategic cash-extraction event to service UPL’s debt rather than an expansion fundraise for Advanta.
• Structural Margin Dilution via the Decco Related-Party Transaction: The internal acquisition of post-harvest treatment player Decco Holdings UK in late 2025 for USD 482.45 million (₹4,282 crore) has permanently altered Advanta’s financial profile. While core seeds previously commanded high EBITDA margins of 24.73%, the consolidation of Decco’s lower-margin coating and post-harvest business has dragged blended EBITDA margins down to 20.4% as of Q1 FY27.
• Premium Sorghum Trait Duopoly Erosion: While Advanta historically held unmatched pricing power with its non-GMO herbicide-tolerant igrowth® technology—charging a premium of USD 20.00 per acre—the competitive entry of S&W Seed’s Double Team™ system has created a aggressive duopoly. This alternative herbicide system is driving customer churn in key geographies like the US Southern Plains due to escalating weed resistance to imidazolinone chemistry.

• Samvardhana Motherson International Limited (SAMIL) is a tier-1 global automotive mega-supplier with established leadership across electrical wiring interconnection systems (EWIS), vision systems, and exterior/interior polymer modules, while accelerating diversification into aerospace, defence, and health & medical sectors.
• Financial performance demonstrates robust top-line momentum and cash-flow expansion, with FY26 consolidated revenue reaching INR 1,257,996 mn (+11.1% YoY; 3-year CAGR of 17.05%), operating cash flow scaling to INR 101,144 mn, and net profit rising to INR 38,597 mn, driven by content-per-vehicle expansion across powertrain-agnostic architectures.
• Strategic execution of non-automotive growth is evidenced by the aerospace division’s revenue expanding nearly tenfold from FY23 to INR 2,447 crore in FY26 with an order book of USD 1.6 billion; near-term performance will depend on margin optimization, M&A integration efficiency, and global automotive OEM build-rate stability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Manipal Health Enterprises (MANIPALH IN) has redeemed the outstanding NCDs worth of INR53B, using the IPO proceeds. The debt reduction is expected to support the company’s focus on profitable growth.
• Manipal Health has other strong margin drivers. The integration of Sahyadri Hospitals, increasing contribution of high-acuity specialties, and ramping-up of greenfield expansions are key margin drivers.
• With long-term structural factors supporting growth of the Indian healthcare delivery market, as a large player with Pan-India presence, Manipal Health is well-positioned to leverage on the growth opportunity.  

• RPSG Ventures Limited operates as the strategic incubation and holding vehicle of the RP-Sanjiv Goenka Group, anchoring a high-growth portfolio across Business Process Management (Firstsource Solutions), Fast-Moving Consumer Goods (Guiltfree Industries / Too Yumm!, Dr. Vaidya’s), Luxury Real Estate (Quest Mall), and Tier-1 Sports Franchises (Lucknow Super Giants, Mohun Bagan Super Giant).
• Consolidated financial performance demonstrates resilient top-line expansion, with revenue growing at a 16.47% 3-year CAGR to INR 113,231.0m in FY26 and reaching INR 35,764.4m in Q1FY27; while statutory net income has been weighed down by incubation and renovation phases, underlying operating cash flow reached INR 8,550.3m in FY26 with positive FCFE of INR 6,026.3m.
• The institutional investment thesis is underpinned by an attractive Sum-of-the-Parts (SOTP) holding company discount, operating margin inflection in the core BPM platform, rapid scale-up in FMCG distribution, and impending catalysts from Quest Mall’s post-renovation relaunch and sports asset monetization.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.